Velcade-Melphalan And Double Stem Cell Transplant Combination Is Feasible In ... The Myeloma Beacon Among patients who received at least one stem cell transplant, median progression-free survival after the first transplant was also 15 months. Median overall survival was 35 months from the first dose of Velcade. For those who went on to receive at ... |
